“By listening to our customers, we developed a universal app with enhanced features to make living with diabetes easier,” Badia Boudaiffa, VP of North America commercial operations for Abbott’s diabetes care business, said in a statement shared with DDBN. “With the new Libre app, Libre users will experience a more user-friendly interface that makes tracking glucose readings and insights easier and streamlines care.”
The new Libre app enables CGM users to track glucose readings and insights, with features including:
- One app for both FreeStyle Libre 2 and FreeStyle Libre 3 systems (sensors include FreeStyle Libre 2, FreeStyle Libre 2 Plus, FreeStyle Libre 3, and FreeStyle Libre 3 Plus);
- FreeStyle Libre 2 users will now see their glucose data automatically displayed in the app, eliminating the need to scan their sensor (This was already a feature for FreeStyle 3 users.);
- New to FreeStyle Libre 3 systems, users can temporarily silence their glucose alarms for up to six hours;
- Optional alarms can discreetly alert users to high or low glucose levels;
- There’s a simplified view of data patterns, enabling users to better understand the impact of food, activity, and insulin on glucose levels.
The app is available on Android and iOS systems and is downloadable from the Apple Store of Google Play.
Freestyle Libre CGMs constitute a significant growth driver at Abbott. In the first quarter of this year, the company grew CGM sales 18.4% year over year to $1.7 billion.
